Argent Biopharma Ltd (ASX: RGT) Share Price and News
Price
$0.12
Movement
0.00 (0.0)
as at 15 May - Closed (20 mins delayed)
52 Week Range
$0.11 - $0.57
1 Year Return
-68.42%
Argent Biopharma Ltd Chart and Price Data
2025
2025
2025
2025
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50
$0.00
$0.25
$0.50
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$8.66 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
72.18 million
Earnings per share
-0.407
Dividend per share
N/A
Year To Date Return
-23.53%
Earnings Yield
N/A
Franking
-
Share Price
$0.12
Day Change
0.00 (0.0)
52 Week Range
$0.11 - $0.57
Yesterday's Close
$0.12
Today's Open
$0.125
Days Range
$0.12 - $0.125
Volume
62,157
Avg. Volume (1 month)
30,237
Turnover
$7,584
as at 15 May - Closed
Argent Biopharma Ltd (ASX: RGT)
Latest News
Share Market News
Why the MGC Pharma (ASX:MXC) share price is 31% higher today
Share Gainers
Why the MGC Pharma (ASX:MXC) share price is smoking the market today
Share Gainers
Why these ASX cannabis shares are starting the week on a high
Share Gainers
Why this ASX cannabis share jumped 12% higher today
Share Gainers
Why FAR, Medical Developments, MGC Pharma, & Western Areas are pushing higher
Share Gainers
Why this ASX cannabis share is charging higher on Tuesday
Share Gainers
Why this ASX cannabis share surged higher today
Share Market News
Buy high, sell low: Canopy Growth Corp dumps Auscann pot stock stake
Share Market News
Why these ASX cannabis shares are on the move today
Share Gainers
Why this ASX cannabis share stormed higher today
Share Market News
Should you still be invested in ASX marijuana shares?
Share Market News
Cannabis company MGC Pharmaceuticals on watch after "transformational event"
RGT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 2nd May 2025 2025-05-02T17:08:23 | Notification of cessation of securities - RGT | YesNo | 5:08pm | 5 | 15k |
| 30th Apr 2025 2025-04-30T09:42:18 | Quarterly Activities/Appendix 4C Cash Flow Report | YesNo | 9:42am | 11 | 585k |
| 24th Apr 2025 2025-04-24T11:40:38 | s708A Cleansing Notice | YesNo | 11:40am | 1 | 322k |
| 24th Apr 2025 2025-04-24T11:35:43 | Application for quotation of securities - RGT | YesNo | 11:35am | 8 | 18k |
| 24th Apr 2025 2025-04-24T11:34:28 | Cancel - Application for quotation of securities - RGT | YesNo | 11:34am | 8 | 18k |
| 23rd Apr 2025 2025-04-23T18:51:19 | s708A Cleansing Notice | YesNo | 6:51pm | 1 | 324k |
| 23rd Apr 2025 2025-04-23T18:46:09 | Application for quotation of securities - RGT | YesNo | 6:46pm | 8 | 18k |
| 23rd Apr 2025 2025-04-23T18:44:19 | Application for quotation of securities - RGT | YesNo | 6:44pm | 8 | 19k |
| 23rd Apr 2025 2025-04-23T18:41:29 | Application for quotation of securities - RGT | YesNo | 6:41pm | 8 | 18k |
| 23rd Apr 2025 2025-04-23T18:41:29 | Application for quotation of securities - RGT | YesNo | 6:41pm | 8 | 18k |
About Argent Biopharma Ltd
MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Nativ Segev on October 21, 2005 and is headquartered in Perth, Australia.
RGT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 14 May 2025 | $0.12 | $-0.01 | -7.69% | 16,031 | $0.12 | $0.13 | $0.12 |
| 13 May 2025 | $0.13 | $-0.02 | -13.33% | 50,366 | $0.15 | $0.16 | $0.12 |
| 12 May 2025 | $0.15 | $0.04 | 34.78% | 30,458 | $0.12 | $0.15 | $0.12 |
| 09 May 2025 | $0.12 | $0.00 | 0.00% | 18,510 | $0.11 | $0.12 | $0.11 |
| 08 May 2025 | $0.12 | $0.00 | 0.00% | 6,295 | $0.12 | $0.12 | $0.12 |
| 07 May 2025 | $0.12 | $0.00 | 0.00% | 26,359 | $0.12 | $0.12 | $0.12 |
| 06 May 2025 | $0.12 | $-0.01 | -8.00% | 72,115 | $0.13 | $0.13 | $0.12 |
| 05 May 2025 | $0.13 | $-0.01 | -7.69% | 12,165 | $0.14 | $0.14 | $0.13 |
| 02 May 2025 | $0.13 | $0.01 | 8.00% | 18,265 | $0.13 | $0.13 | $0.13 |
| 01 May 2025 | $0.13 | $-0.01 | -7.69% | 17,984 | $0.12 | $0.13 | $0.12 |
| 30 Apr 2025 | $0.13 | $-0.01 | -7.41% | 88,268 | $0.14 | $0.14 | $0.12 |
| 29 Apr 2025 | $0.14 | $0.00 | 0.00% | 7,498 | $0.14 | $0.14 | $0.14 |
| 28 Apr 2025 | $0.14 | $-0.02 | -13.33% | 21,745 | $0.15 | $0.16 | $0.14 |
| 24 Apr 2025 | $0.15 | $-0.01 | -6.25% | 24,469 | $0.17 | $0.17 | $0.15 |
| 23 Apr 2025 | $0.16 | $-0.02 | -11.11% | 88,450 | $0.20 | $0.20 | $0.16 |
| 22 Apr 2025 | $0.18 | $0.01 | 5.71% | 9,189 | $0.19 | $0.19 | $0.18 |
| 17 Apr 2025 | $0.18 | $0.00 | 0.00% | 27,830 | $0.18 | $0.18 | $0.18 |
| 15 Apr 2025 | $0.18 | $-0.01 | -5.56% | 38,512 | $0.20 | $0.20 | $0.18 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Oct 2024 | Roby Zomer | Buy | 4,000,000 | $1,640,000 |
As advised by the company.
|
| 10 Sep 2024 | Roby Zomer | Buy | 1,258,500 | $503,400 |
Off-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Daniel Robinson | Non-Executive Director | Dec 2023 |
Mr Robinson has been appointed as a Non-Executive Director of the Company effective immediately. Mr Robinson has over 20 years of experience in a broad range of corporate roles across stockbroking, corporate advisory, investor relations and governance. He is an experienced Company Secretary and Director of both private and listed companies. Additionally, Mr Robinson is a Member of the Australian Institute of Company Directors.
|
| Mr Roby Reuven Zomer | Chief Executive OfficerManaging Director | Feb 2016 |
Mr Zomer is an executive with experience in the biopharmaceutical and biotech industries. As the CEO of the company, Roby has demonstrated has driven strategic growth, managed financial operations, and ensured compliance with industry-specific standards. He also served as the Chairman of the Board for Graft Polymer, overseeing the implementation of advanced polymer solutions in the Biotech, Automotive and Recycling sectors. Roby's entrepreneurial background includes founding and leading Green City Urban Recycling, a pioneering Israeli company focused on biofuel production. His innovative work in this field contributed to national energy independence initiatives and led to the company's acquisition by Rafael Advanced Defense Systems. With an industrial engineering and management foundation, Roby Zomer brings a blend of technical and strategic skills to his professional endeavors.
|
| Mr Gary Hermon | Non-Executive Director | Mar 2025 |
Mr Hermon is a Company Director with over 30 years of experience in telecommunications, electrical systems, and infrastructure rollout. Throughout his career, he has managed projects for clients, including Hewlett-Packard, the Victorian Government, BP, and ExxonMobil. Previously, Mr Hermon founded Hercomm Cables & Security, where he managed nationwide rollouts for Hewlett-Packard and the Victorian Government. He also has experience overseeing electrical systems and communications for BP and ExxonMobil in Indonesia, India, and Papua New Guinea.
|
| Mr Rowan Harland | Company Secretary | Mar 2023 |
-
|
| Rowan Harland | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Oak Capital Partners Llc | 8,370,718 | 17.29% |
| Group Capital Llc | 3,913,812 | 8.09% |
| David Safren | 3,405,016 | 7.03% |
| Citicorp Nominees Pty Limited | 2,301,084 | 4.75% |
| Shlomie Bierman | 2,230,874 | 4.61% |
| Computershare Clearing Pty Ltd <Ccnl Di A/C> | 2,099,936 | 4.34% |
| Isamar Margareten | 1,956,906 | 4.04% |
| Mr Shachar Shimony | 1,933,000 | 3.99% |
| Yaakov Safren | 1,643,802 | 3.40% |
| Jacob Goldstein | 1,623,072 | 3.35% |
| Yoram Drucker | 1,604,664 | 3.32% |
| Yosef Safren | 1,565,526 | 3.23% |
| Shalom Safren | 1,448,112 | 2.99% |
| Bioheka Limited | 1,258,500 | 2.60% |
| Mrs Yifat Steuer | 1,117,194 | 2.31% |
| Eliron Yaron | 750,000 | 1.55% |
| A1 Invest Llc | 625,000 | 1.29% |
| Mr Itay David Nissim | 600,000 | 1.24% |
| Mr Amir Polak | 592,626 | 1.22% |
| Joseph Schwartz | 547,934 | 1.14% |